UNIGE document Scientific Article
previous document  unige:45240  next document
add to browser collection
Title

Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial
Authors
Hess, Viviane
Salzberg, Marc
Borner, Markus
Morant, Rudolf
Roth, Arnaud
Ludwig, Christian
Herrmann, Richard
Published in Journal of Clinical Oncology. 2003, vol. 21, no. 1, p. 66-8
Abstract Preclinical studies indicate positive interactions between capecitabine, an oral fluorouracil precursor, and gemcitabine, the current standard treatment for advanced pancreatic carcinoma (APC). In this study, we investigated the addition of capecitabine to gemcitabine treatment for patients with APC.
Keywords Aged — Antineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic use — Deoxycytidine/administration & dosage/adverse effects/analogs & derivatives — Female — Fluorouracil/analogs & derivatives — Humans — Male — Maximum Tolerated Dose — Middle Aged — Pancreatic Neoplasms/drug therapy/mortality — Survival Rate — Switzerland/epidemiology
Identifiers
PMID: 12506172
Full text
Article (Published version) (52 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://jco.ascopubs.org/content/21/1/66.long
Structures
Faculté de médecine / Section de médecine clinique / Département de médecine
Faculté de médecine / Section de médecine clinique / Département de chirurgie
Research group Groupe Roth Arnaud (oncologie) (285)
Citation
(ISO format) 		HESS, Viviane et al. Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial. In: Journal of Clinical Oncology, 2003, vol. 21, n° 1, p. 66-8. https://archive-ouverte.unige.ch/unige:45240

348 hits

0 download

Contact an author

Update request

Update

Deposited on : 2015-01-14

Export document
Format :
Citation style :